SCHEMBL17844397

SCHEMBL17844397

COc1ccnc2c1c(C1=CCN(C(=O)O)CC1)nn2COCC[Si](C)(C)C

nearest known ligand 0.35

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
QDPR P09417 1/20 0.35
CCNT1 O60563 17/20 0.34
CDK9 P50750 17/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17844418 0.89 LIMK1 (0.34)
SCHEMBL17837904 0.89 GRM1 (0.42) CDK9
SCHEMBL17844432 0.89 TRPV1 (0.33)
SCHEMBL17837729 0.79 GRM1 (0.44) CCNT1CDK9
SCHEMBL17844574 0.79 CHRM4 (0.35)
SCHEMBL17837491 0.78 GRM1 (0.41)
SCHEMBL17837694 0.73 GRM5 (0.47)
SCHEMBL17837585 0.70 ALDH1A1 (0.40)
SCHEMBL28824082 0.70 TRPV1 (0.34)
SCHEMBL17844426 0.69 KLKB1 (0.34)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3233829-A1 PYRIMIDINE AND TRIAZINE DERIVATIVES AND THEIR USE AS AXL INHIBITORS Pfizer Inc (US) 2017-10-25 EP disclosed
WO-2016097918-A1 PYRIMIDINE AND TRIAZINE DERIVATIVES AND THEIR USE AS AXL INHIBITORS PFIZER INC. (US) 2016-06-23 WO disclosed